Open this publication in new window or tab >>Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Cell Biology.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Cell Biology, Integrative Physiology.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Cell Biology.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Immunology, Genetics and Pathology, Clinical Immunology.
3Department of Clinical Sciences, Danderyd Hospital, Division of Internal Medicine, Karolinska Institutet, Stockholm, Sweden.
A.I.Virtanen Institute, University of Eastern Finland, Kuopio, Finland.
Turku University Hospital, Department of Vascular Surgery, Turku, Finland.
Department of Cell and Molecular Biology, Karolinska Institute, Stockholm, Sweden.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Immunology, Genetics and Pathology, Clinical Immunology.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Cell Biology, Integrative Physiology.
Department of Cell and Molecular Biology, Karolinska Institute, Stockholm, Sweden. Department of Physiology, Development and Neuroscience, University of Cambridge, United.
Department of Clinical Sciences, Danderyd Hospital, Division of Internal Medicine, Karolinska Institutet, Stockholm, Sweden.
Kuopio University Hospital, Heart Center, Kuopio, Finland.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Cell Biology, Integrative Physiology.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Cell Biology, Integrative Physiology.
Show others...
2021 (English)In: Circulation Research, ISSN 0009-7330, E-ISSN 1524-4571, Vol. 128, no 11, p. 1694-1707Article in journal (Refereed) Published
Abstract [en]
Rationale: Ischemic injuries remain a leading cause of mortality and morbidity worldwide, and restoration of functional blood perfusion is vital to limit tissue damage and support healing.
Objective: To reveal a novel role of macrophages in reestablishment of functional tissue perfusion following ischemic injury that can be targeted to improve tissue restoration.
Methods and Results: Using intravital microscopy of ischemic hindlimb muscle in mice, and confocal microscopy of human tissues from amputated legs, we found that macrophages accumulated perivascularly in ischemic muscles, where they expressed high levels of iNOS (inducible nitric oxide [NO] synthase). Genetic depletion of iNOS specifically in macrophages (Cx3cr1-CreERT2;Nos2(fl/fl) or LysM-Cre;Nos2(fl/fl)) did not affect vascular architecture but highly compromised blood flow regulation in ischemic but not healthy muscle, which resulted in aggravated ischemic damage. Thus, the ability to upregulate blood flow was shifted from eNOS (endothelial)-dependence in healthy muscles to completely rely on macrophage-derived iNOS during ischemia. Macrophages in ischemic muscles expressed high levels of CXCR4 (C-X-C chemokine receptor type 4) and CCR2 (C-C chemokine receptor type 2), and local overexpression by DNA plasmids encoding the corresponding chemokines CXCL12 (stromal-derived factor 1) or CCL2 (chemokine [C-C motif] ligand 2) increased macrophage numbers, while CXCL12 but not CCL2 induced their perivascular positioning. As a result, CXCL12-overexpression increased the number of perfused blood vessels in the ischemic muscles, improved functional muscle perfusion in a macrophage-iNOS-dependent manner, and ultimately restored limb function.
Conclusions: This study establishes a new function for macrophages during tissue repair, as they regulate blood flow through the release of iNOS-produced NO. Further, we demonstrate that macrophages can be therapeutically targeted to improve blood flow regulation and functional recovery of ischemic tissues.
Place, publisher, year, edition, pages
Lippincott Williams & Wilkins, 2021
National Category
Cell and Molecular Biology
Identifiers
urn:nbn:se:uu:diva-395532 (URN)10.1161/CIRCRESAHA.120.318380 (DOI)000656056100011 ()33878889 (PubMedID)
Funder
Swedish Research Council, K2012-99xSwedish Research Council, 65X12219-15-6Swedish Research Council, 5570x-15043Swedish Research Council, O4X-08646Swedish Research Council, K2015-54X-12219-19-4Ragnar Söderbergs stiftelse, K2015-54X-12219-19-4Knut and Alice Wallenberg FoundationSwedish Foundation for Strategic Research Insamlingsstiftelsen Diabetes WellnessSwedish Child Diabetes FoundationNovo NordiskSwedish Society for Medical Research (SSMF)Fredrik och Ingrid Thurings StiftelseErnfors FoundationEXODIAB - Excellence of Diabetes Research in SwedenSwedish Diabetes Association
Note
E. Vågesjö, K. Parv, D. Ahl, and G. Christoffersson contributed equally.
2019-10-202019-10-202024-01-15Bibliographically approved